Grifols (GRFS) Gross Profit Growth (3y) (2013 - 2020)
Grifols (GRFS) Gross Profit Growth (3y) (2013 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 9.68% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 3.51% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.19% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 10.80% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 11.87% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 6.47% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 251.01% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 7.88% |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4.17% |
| Dec 31, 2019 | 52.33% |
| Dec 31, 2018 | 45.14% |
| Jun 30, 2018 | 5.51% |
| Mar 31, 2018 | 5.62% |
| Dec 31, 2017 | 51.50% |
| Jun 30, 2017 | -89.67% |
| Mar 31, 2017 | 0.05% |
| Dec 31, 2016 | 4.25% |
| Sep 30, 2016 | 3.51% |
| Jun 30, 2016 | 4.40% |
| Dec 31, 2015 | 10.17% |
| Sep 30, 2015 | 8.73% |
| Jun 30, 2015 | 6.91% |
| Mar 31, 2015 | 5.48% |
| Dec 31, 2014 | 14.03% |
| Sep 30, 2014 | 14.84% |
| Jun 30, 2014 | 1,228.00% |
| Mar 31, 2014 | 52.22% |
| Dec 31, 2013 | 103.37% |